Knockdown of MALAT1 attenuates high-glucose-induced angiogenesis and inflammation via endoplasmic reticulum stress in human retinal vascular endothelial cells-Reference-Cited by-同舟云学术

Knockdown of MALAT1 attenuates high-glucose-induced angiogenesis and inflammation via endoplasmic reticulum stress in human retinal vascular endothelial cells

Published:2020-04 Issue: Volume:124 Page:109699
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Wang Yuan,Wang Ling,Guo Hui,Peng Yun,Nie Danyao,Mo Jinsong,Ye Lin

Funder

General program of Shenzhen municipal Health Commission

National Natural Science Foundation of China

Shenzhen Sanming Project

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference43 articles.

1. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease;Antonetti;Diabetes,2006

2. Challenges in elucidating the genetics of diabetic retinopathy;Kuo;JAMA Ophthalmol.,2014

3. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005–2050;Saaddine;Arch. Ophthalmol.,2008

4. Pharmacologic management of diabetic retinopathy;Uemura;J. Biochem.,2018

5. Patients’ preferences for involvement in the decision-making process for treating diabetic retinopathy;Marahrens;BMC Ophthalmol.,2017

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-mediated lncRNA-induced immune cell plasticity in cancer immunopathogenesis;International Immunopharmacology;2024-11

2. Role of long noncoding RNAs in diabetes-associated peripheral arterial disease;Cardiovascular Diabetology;2024-07-24

3. Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions;International Journal of Molecular Sciences;2024-02-09

4. Non-coding RNAs and exosomal non-coding RNAs in diabetic retinopathy: A narrative review;International Journal of Biological Macromolecules;2024-02

5. The Role of TRIM Proteins in Vascular Disease;Current Vascular Pharmacology;2024-01